Celecoxib inhibits gastric adenocarcinoma growth via inducing expression of human nonsteroidal anti-inflammatory drug activated gene

Journal of Sichuan University (Medical Science)

Volumn 40, Issue 6, 2009, Pages 1029-1032

  Wang, Rui ^a   Ciren, Yang Jin ^a   Yang, Jin Lin ^a   Zhang, Bo ^a   Chen, Jia Ping ^a   Tang, Cheng Wei ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Celecoxib; COX 2; Gastric cancer; NSAIDs activated gene 1

Indexed keywords

EID: 73049097055     PISSN: 1672173X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Lim L, Michael M, Mann GB, et al. Adjuvant therapy in gastric cancer. J Clin Oncol, 2005;23(25):6220-6232.
2. Zhang D, Fan D. Multi-drug resistance in gastric cancer: recent research advances and ongoing therapeutic challenges. Expert Rev Anticancer Ther, 2007;7(10):1369-1378.
3. Sun WH, Sun YL, Fang RN, et al. Expression of cyclooxygenase-2 and matrix metalloproteinase-9 in gastric carcinoma and its correlation with angiogenesis. Jpn J Clin Oncol, 2005;35(12):707-713.
4. Chinese source
5. Cho SJ, Kim N, Kim JS, et al. The anti-cancer effect of COX-2 inhibitors on gastric cancer cells. Dig Dis Sci, 2007;52(7):1713-1721.
6. Julie G, Jaffer A. Thinking in and out of the box when it comes to gastric cancer and cyclooxygenase-2. J Clin Oncol, 2007;25(31):4865-4867.
7. Wu YL, Fu SL, Zhang YP, et al. Cyclooxygenase-2 inhibitors suppress angiogenesis and growth of gastric cancer xenografts. Biomed Pharmacother, 2005;59 (Suppl 2):289-292.
8. Kismet K, Akay MT, Abbasoglu O, et al. Celecoxib: a potent cyclooxygenase-2 inhibitor in cancer prevention. Cancer Detect Prev, 2004;28(2):127-142.
9. Tegeder I, Pfeilschifter J, Geisslinger G. Cyclooxygenase independent actions of cyclooxygenase inhibitors. FASEB J, 2001;15(1):2057-2072.
10. Murono S, Yoshiraki T, Sato H, et al. Aspirin inhibits tumor cell invasiveness induced by epstein-barr virus latent membrane protein 1 through suppression of matrix metalloproteinase-9 expression. Cancer Res, 2000;60(5):2555-2561.
11. Baek SJ, Kim JS, Lee SH, et al. Cyclooxygenase inhibitors induce the expression of the tumor suppressor gene EGR-1, which results in the up-regulation of NAG-1, an antitumorigenic protein. Mol Pharmacol, 2005;67(2):356-364.
12. Baek SJ, Kim KS, Nixon JB, et al. Cyclooxygenase inhibitors regulate the expression of a TGF-beta superfamily member that has proapoptotic and antitumorigenic activities. Mol Pharmacol, 2001;59(4):901-908.
13. Tae JJ, Hyeock JK, Jung RK, et al. Non-steroidal antiinflammatory drug activated gene (NAG-1) expression is closely related to death receptor-4 and-5 induction, which may explain sulindac sulfide induced gastric cancer cell apoptosis. Carcinogenesis, 2004;25(10):1853-1858.
14. Baek SJ, Eling TE. Changes in gene expression contribute to cancer prevention by COX inhibitors. Prog Lipid Res, 2006;45(1):1-16.